You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -13,731.3% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -3.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 847.6 | 0.0 |
| Price / Book value | 8.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | n/a | -11.71 | -15.21p | -46.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -23.99 | -26.08p | -12.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -28.44 | -36.17p | -2.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.21 | -29.43 | -36.75p | -2.7 | 0.0 | n/a | n/a | 0.0% |
| 4D Pharma inks collaboration with Merck and Pfizer Sharecast News | 08 Feb |
|---|---|
| 4D Pharma makes progress with MRx0518 development programme Sharecast News | 03 Feb |
| Next part of tumour trial begins for 4D Pharma Sharecast News | 06 Jul |
| Holding(s) in Company | 26-Feb-21 12:53 |
|---|---|
| Posting of Circular | 26-Feb-21 07:02 |
| U.S. SEC Declares Registration Statement Effective | 26-Feb-21 07:01 |
| Microbiome Leaders Panel Event | 16-Feb-21 07:00 |
| Holding(s) in Company | 08-Feb-21 07:46 |